Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Julien Kirchgesner

Associate Professor

University Name

France

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

100%

Pharmacotherapy

40%

Inflammatory Bowel Disease

80%

Gastroenterology

80%

Inflammatory Disease

70%

Biologic Therapy

50%

Anti-inflammatory Research

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles19

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study

Article Link

Year:

2024

Strengthening Real‐World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach

Article Link

Year:

2024

Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus

Article Link

Year:

2024

A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness

Article Link

Year:

2024

Inflammatory bowel diseases and eosinophilic oesophagitis: Two overlapping disorders?

Article Link

Year:

2024

Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases

Article Link

Year:

2024

Editorial: Pip pip to PIPs (post‐ inflammatory polyps) as a neoplasia risk factor in IBD? Authors' reply

Article Link

Year:

2023

Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies

Article Link

Year:

2023

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases

Article Link

Year:

2023

Letter: histologic disease activity and colorectal neoplasia risk—authors' reply

Article Link

Year:

2023

Perianal fistulizing Crohn's disease and overall risk of cancer: No red flag

Article Link

Year:

2023

Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post‐inflammatory polyps

Article Link

Year:

2023

Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases

Article Link

Year:

2023

Inflammatory bowel diseases and eosinophilic oesophagitis: Two overlapping disorders?

Article Link

Year:

2023

Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID

Article Link

Year:

2023

Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies

Article Link

Year:

2023

Risk of acute arterial events associated with treatment of inflammatory bowel diseases: a nationwide Danish cohort study

Article Link

Year:

2022

C-reactive protein values after surgery for inflammatory bowel disease: is it still a good marker for intra-abdominal complication? A retrospective cohort study of 347 procedures : CRP after inflammatory bowel disease surgery.

Article Link

Year:

2022

Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule?

Article Link

Year:

2022

Collaborators11

Glen Doherty

UCD Full Clinical Professor

Dublin City University

IRELAND

Grégory DA COSTA

Institut National de Recherche pour l'Agriculture l'Alimentation et l'Environnement

FRANCE

nathalie ROLHION

INSERM

FRANCE

Javier Pérez Gisbert

Tenure Professor

Universidad Autónoma de Madrid

SPAIN

Jérémie H. Lefèvre

FRANCE

Flavio Caprioli

Associate professor

Università degli Studi di Torino

ITALY

Florian N Loch

Charité - Universitätsmedizin Berlin

GERMANY

Mathieu Uzzan

FRANCE

Sebastian Schneeweiss

Harvard University

UNITED STATES

Sebastian Schölch

Head

German Cancer Research Center (DKFZ)

GERMANY

Daniel Ward

Aalborg University

DENMARK

How do I reach out?

Meet Kite AI